NASDAQ
Coya Therapeutics, Inc. (COYA) has a price/sales ratio of 12.21x as of Friday, May 22, 2026. This represents a 31.61% increase compared to its 12-month average of 9.28x. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.
No price data available for this timeframe.